VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 665 filers reported holding VANECK VECTORS ETF TR in Q3 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,169,731 | -46.7% | 154,951 | -40.3% | 0.34% | -42.3% |
| Q2 2023 | $7,818,452 | -6.7% | 259,663 | +0.2% | 0.60% | -9.4% |
| Q1 2023 | $8,379,750 | -13.3% | 259,034 | -23.2% | 0.66% | -13.4% |
| Q4 2022 | $9,669,741 | +2950.4% | 337,395 | +2816.6% | 0.76% | +3075.0% |
| Q2 2022 | $317,000 | 0.0% | 11,568 | +39.8% | 0.02% | +20.0% |
| Q1 2022 | $317,000 | +48.8% | 8,274 | +24.5% | 0.02% | +53.8% |
| Q4 2021 | $213,000 | -83.3% | 6,646 | -82.3% | 0.01% | -84.1% |
| Q2 2021 | $1,272,000 | +56.7% | 37,448 | +49.9% | 0.08% | +36.7% |
| Q1 2021 | $812,000 | +24.0% | 24,981 | +37.4% | 0.06% | +22.4% |
| Q4 2020 | $655,000 | +89.9% | 18,179 | +106.6% | 0.05% | +69.0% |
| Q3 2020 | $345,000 | +35.3% | 8,800 | +1.1% | 0.03% | +16.0% |
| Q4 2019 | $255,000 | +9.9% | 8,700 | 0.0% | 0.02% | +4.2% |
| Q3 2019 | $232,000 | – | 8,700 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 1,221,955 | $36,011,000 | 14.81% |
| New Harbor Financial Group, LLC | 1,155,900 | $34,064,000 | 14.01% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $21,764,000 | 13.56% |
| Hollow Brook Wealth Management LLC | 670,275 | $19,753,000 | 12.24% |
| Grand Central Investment Group | 293,243 | $8,642,000 | 11.46% |
| BW Gestao de Investimentos Ltda. | 940,800 | $27,725,000 | 8.44% |
| Slate Path Capital LP | 5,930,000 | $174,757,000 | 7.97% |
| Nokomis Capital, L.L.C. | 512,628 | $15,107,000 | 7.14% |
| Plaisance Capital LLC | 288,000 | $8,487,000 | 6.05% |
| Guild Investment Management, Inc. | 200,114 | $5,897,000 | 5.68% |